Immutable evidence record · ticker

MoonLake Immunotherapeutics (MLTX)

Published as observed on 21 August 2026 at 11:58 BST.

MoonLake Immunotherapeutics has a negative company news read. Its latest completed weekly trend is positive.

As of
21 Aug 2026, 11:58
Scope
company and instrument
Evidence
18 items
Independent sources
5
Country
United States
Sector
Healthcare
Previous read
48.000
Change
-4.000

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, MoonLake Immunotherapeutics (MLTX), 2026-08-21, https://sharemaestro.com/evidence/82c55c95-2875-4be2-af3a-1f833d29053d/
Record checksum a24f473947edc4899ae017d8138e3719274d472aae4ac236c0153dd382d8a425

Evidence context